Clinician Perspectives of COVID-19-Related Cancer Drug Funding Measures in Ontario

by Naipaul, Rohini D., Mercer, Rebecca E., Chan, Kelvin K. W., Yeung, Lyndee, Forbes, Leta, Gavura, Scott
Published 2021

Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration

by Chan, Kelvin, Nam, Seungree, Evans, Bill, de Oliveira, Claire, Chambers, Alexandra, Gavura, Scott, Hoch, Jeffrey, Mercer, Rebecca E, Dai, Wei Fang, Beca, Jaclyn, Tadrous, Mina, Isaranuwatchai, Wanrudee
Published 2020

Are population‐based patient‐reported outcomes associated with overall survival in patients with advanced pancreatic cancer?

by Dai, Wei Fang, Beca, Jaclyn, Guo, Helen, Isaranawatchai, Wanrudee, Schwartz, Deborah, Naipaul, Rohini, Arias, Jessica, Qiao, Yao, Gavura, Scott, Redmond‐Misner, Ruby, Ismail, Zahra, Barbera, Lisa, Chan, Kelvin
Published 2019

Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada

by Dai, Wei Fang, Beca, Jaclyn M., Croxford, Ruth, Isaranawatchai, Wanrudee, Menjak, Ines B., Petrella, Teresa M., Mittmann, Nicole, Earle, Craig C., Gavura, Scott, Hanna, Timothy P., Chan, Kelvin K.W.
Published 2020

Real-World Cost-Effectiveness of Bevacizumab With First-Line Combination Chemotherapy in Patients With Metastatic Colorectal Cancer: Population-Based Retrospective Cohort Studies i...

by Pataky, Reka E., Beca, Jaclyn, Tran, David, Dai, Wei Fang, Dvorani, Erind, Isaranuwatchai, Wanrudee, Peacock, Stuart, Alvi, Riaz, Cheung, Winson Y., Earle, Craig C., Gavura, Scott, Chan, Kelvin K. W.
Published 2021

The Association of Drug-Funding Reimbursement With Survival Outcomes and Use of New Systemic Therapies Among Patients With Advanced Pancreatic Cancer

by Raphael, Michael J., Raskin, William, Habbous, Steven, Tai, Xiaochen, Beca, Jaclyn, Dai, Wei F., Arias, Jessica, Forbes, Leta, Gavura, Scott, Biagi, James J., Earle, Craig C., Chan, Kelvin K. W.
Published 2021

Cost‐effectiveness of second‐line ipilimumab for metastatic melanoma: A real‐world population‐based cohort study of resource utilization

by Lu, Brandon, Dai, Wei Fang, Croxford, Ruth, Isaranuwatchai, Wanrudee, Beca, Jaclyn, Menjak, Ines B., Petrella, Teresa M., Mittmann, Nicole, Earle, Craig C., Gavura, Scott, Mercer, Rebecca E., Hanna, Timothy P., Chan, Kelvin K. W.
Published 2023

Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: a population-based analysis

by Khor, Sara, Beca, Jaclyn, Krahn, Murray, Hodgson, David, Lee, Linda, Crump, Michael, Bremner, Karen E, Luo, Jin, Mamdani, Muhammad, Bell, Chaim M, Sawka, Carol, Gavura, Scott, Sullivan, Terrence, Trudeau, Maureen, Peacock, Stuart, Hoch, Jeffrey S
Published 2014

Real-World Cost-Effectiveness of First-Line Gemcitabine Plus Nab-Paclitaxel vs FOLFIRINOX in Patients With Advanced Pancreatic Cancer

by Arciero, Vanessa, Luo, Jin, Parmar, Ambica, Dai, Wei Fang, Beca, Jaclyn M, Raphael, Michael J, Isaranuwatchai, Wanrudee, Habbous, Steven, Tadrous, Mina, Earle, Craig C, Biagi, Jim J, Mittmann, Nicole, Arias, Jessica, Gavura, Scott, Chan, Kelvin K W
Published 2022

Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis

by Chan, Kelvin K. W., Guo, Helen, Cheng, Sierra, Beca, Jaclyn M., Redmond‐Misner, Ruby, Isaranuwatchai, Wanrudee, Qiao, Lucy, Earle, Craig, Berry, Scott R., Biagi, James J., Welch, Stephen, Meyers, Brandon M., Mittmann, Nicole, Coburn, Natalie, Arias, Jessica, Schwartz, Deborah, Dai, Wei F., Gavura, Scott, McLeod, Robin, Kennedy, Erin D.
Published 2019

Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, Canada

by Habbous, Steven, Tai, Xiaochen, Beca, Jaclyn M, Arias, Jessica, Raphael, Michael J., Parmar, Ambica, Crespo, Andrea, Cheung, Matthew C, Eisen, Andrea, Eskander, Antoine, Singh, Simron, Trudeau, Maureen, Gavura, Scott, Dai, Wei Fang, Irish, Jonathan, Krzyzanowska, Monika, Lapointe-Shaw, Lauren, Naipaul, Rohini, Peacock, Stuart, Yeung, Lyndee, Forbes, Leta, Chan, Kelvin K. W.
Published 2022

Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue...

by Parmar, Ambica, Dai, Wei Fang, Dionne, Francois, Geirnaert, Marc, Denburg, Avram, Ahuja, Tarry, Beca, Jaclyn, Bouchard, Sylvie, Chambers, Carole, Hunt, Melissa J., Husereau, Don, Lungu, Elena, McDonald, Valerie, Mercer, Rebecca E., Mitera, Gunita, Muñoz, Caroline, Naipaul, Rohini, Peacock, Stuart, Potashnik, Tanya, Tadrous, Mina, Takhar, Pam, Taylor, Marianne, Trudeau, Maureen, Wasney, Danica, Gavura, Scott, Chan, Kelvin K. W.
Published 2023